Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 4,417-4,428 of 5,650
Drug study icon
RecruitingNCT07499440

Safety and Efficacy of HB-1 for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Bruce
PTSDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Australia
Sponsor
HB BioTech, LLC
Condition
PTSD
Drug study icon
RecruitingISRCTN64695913

Safety and efficacy study of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)

This study is looking at whether There is a 14-day screening period and a 3 to 7-day placebo washout period before randomisation of the participants for the trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Colombia
SchizophreniaOtherOver 18 Years
Countries
United States, Colombia, Germany, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Drug study icon
RecruitingNCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to Iloperidone, but direct benefit is not guaranteed.

Multiple locations, including Little Rock
Schizophrenia, BipolarityDrugFrom 12 Years to 17 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia, Bipolarity
Drug study icon
RecruitingNCT06229210

Safety and Tolerability study of Lumateperone in Pediatric people with Schizophrenia, Bipolarity or Autism Spectrum Disorder

This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Phoenix
Bipolarity, SchizophreniaDrugFrom 5 Years to 17 Years
Countries
United States, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Schizophrenia
Behavioral study icon
RecruitingNCT06465381

Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide prevention in Mozambique

This study exists to understand what helps cognitive behavioural therapy, a structured talking treatment, work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Beira
SuicidalityBehavioral
Countries
Mozambique
Sponsor
University of Washington
Condition
Suicidality
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.